Court Opinion

ID: 4552737
Source: CourtListenerOpinion
Date Created: 2020-08-03 15:00:22.162276+00
Date Added: 2024-06-11T13:09:25.398513
License: Public Domain

19-1095
    In re Omega Healthcare Inv’rs, Inc. Sec. Litig.
                       UNITED STATES COURT OF APPEALS
                            FOR THE SECOND CIRCUIT
                                    ______________

                                  August Term 2019

                (Argued: November 13, 2019 | Decided: August 3, 2020)

                                  Docket No. 19-1095

                                   ROYCE SETZER,

                                            Lead Plaintiff-Appellant,

                                 EARL HOLTZMAN,

                                            Plaintiff-Appellant,

      DROR GRONICH, Individually and on behalf of all others similarly situated,

                                            Plaintiff,

       STEVEN KLEIN, Individually and on behalf of all others similarly situated,

                                            Consolidated Plaintiff,

                                           v.

    OMEGA HEALTHCARE INVESTORS, INC., C. TAYLOR PICKETT, ROBERT O.
                  STEPHENSON, DANIEL J. BOOTH,

                                           Defendants-Appellees.
                                    ______________

    Before:
                  LEVAL, WESLEY, and LIVINGSTON, Circuit Judges.
1
       Plaintiffs-Appellants brought this putative class action against Omega
Healthcare Investors, Inc., a publicly traded real estate investment trust that
invests in healthcare facilities, and against Omega’s chief executives, asserting
claims under Section 10(b) and 20(a) of the Securities Exchange Act of 1934, 15
U.S.C. §§ 78j(b), 78t(a), and Rule 10b-5, 17 C.F.R. § 240.10b–5. Plaintiffs claim that
Omega misled investors by failing to disclose a $15 million working capital loan it
made to one of its major tenants, Orianna Health Systems. According to Plaintiffs,
this omission hid from investors the true magnitude of Orianna’s solvency
problems. The district court dismissed Plaintiffs’ claims for, among other reasons,
insufficiently alleging scienter.
       Because we find that the complaint adequately alleges that Omega acted
with the requisite scienter in failing to disclose the loan, we REVERSE and
REMAND for proceedings consistent with this opinion.
                                  _________________

             JACOB A. GOLDBERG, (David Dean, on the brief) The Rosen Law
                 Firm, P.A., Jenkintown, PA, for Plaintiffs-Appellants.

             ERIC RIEDER, (Heather S. Goldman, on the brief), Bryan Cave
                  Leighton Paisner, LLP, New York, NY, for Defendants-Appellees.
                             _________________

WESLEY, Circuit Judge:

      Plaintiffs-Appellants, Royce Setzer, Earl Holtzman, Dror Gronich, and

Steven Klein, brought this putative class action against Omega Healthcare

Investors, Inc., a publicly traded Maryland corporation that invests in healthcare

facilities, and against Omega’s chief executives. Plaintiffs assert claims under

Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange

                                          2
Act”), 15 U.S.C. §§ 78j(b), 78t(a), and Rule 10b–5, 17 C.F.R. § 240.10b–5, on behalf

of a putative class of investors who purchased or otherwise acquired Omega’s

securities between May 3, 2017 and October 31, 2017 (the “Class Period”).

Plaintiffs claim that Omega misled investors by failing to disclose a $15 million

working capital loan it made to one of its major tenants, Orianna Health Systems.

According to Plaintiffs, this omission hid from investors an accurate picture of

Orianna’s financial difficulties.    The district court dismissed the complaint,

holding, inter alia, that although the non-disclosure of the loan amounted to a

material omission, Plaintiffs failed to plead a strong inference that Omega acted

with the requisite scienter.

      Because we find that the complaint adequately alleges that Omega acted

with scienter in failing to disclose the loan, we reverse the district court’s decision

and remand for proceedings consistent with this opinion.

                                          3
                                      BACKGROUND

         I.     Facts 1

         Omega is a self-administered real estate investment trust that invests in

healthcare facilities, such as skilled nursing and assisted living facilities. Omega

either owns the properties and leases them to the facility operators, or it provides

operators with mortgage financing. Omega reports its financial performance to

the market through its Funds from Operations (“FFO”) and Adjusted Funds from

Operations (“AFFO”) metrics. Thus, Omega’s FFO and AFFO primarily reflect

rents paid by its operators. 2

1Because we review de novo a dismissal pursuant to Federal Rule of Civil Procedure
12(b)(6), we largely take the facts from Plaintiffs’ complaint and assume them to be true.
See Kalnit v. Eichler, 264 F.3d 131, 137–38 (2d Cir. 2001).
2
    According to Omega’s 2017 10-K:
         NAREIT [National Association of Real Estate Investment Trusts] FFO is a
         non-GAAP financial measure. We use NAREIT FFO as one of several
         criteria to measure the operating performance of our business. We further
         believe that by excluding the effect of depreciation, amortization,
         impairment on real estate assets and gains or losses from sales of real estate,
         all of which are based on historical costs and which may be of limited
         relevance in evaluating current performance, NAREIT FFO can facilitate
         comparisons of operating performance between periods and between other
         REITs.
J.A. 138.
                                               4
      At all relevant times, Defendant C. Taylor Pickett served as Omega’s chief

executive officer; Defendant Robert O. Stephenson served as the chief financial

officer; and Defendant Daniel J. Booth served as the chief operating officer

(together, with Omega, “Defendants”).

      By late 2016 and early 2017, Omega’s second largest operator, Orianna, 3

began experiencing severe financial difficulties and became delinquent on its rent.

Orianna operated 59 skilled nursing facilities across the country, representing

seven percent of Omega’s investment portfolio at that time (roughly $619 million

in gross investment). In response to Orianna’s financial troubles, on May 2, 2017,

Omega provided a $15 million working capital loan to the company (the “Loan”). 4

             A.     First Quarter: January 1, 2017 through March 31, 2017

      Two days after it made the Loan, Omega held a conference call with analysts

to discuss its results for the first quarter of 2017. On the call, Defendant Booth

described    Orianna’s    “performance      pressure,”   which     he   claimed    was

3
 Orianna is also identified in Omega’s public filings as “New ARK Investments, Inc.,”
the name of its affiliate.
4
 The parties sometimes refer to the Loan as an $18.8 million line of credit. That figure
includes half of the accumulated interest on the Loan. The amount disbursed, however,
was $15 million.
                                           5
“exacerbated” by “complete replacement of senior management” in 2016. J.A. 25

¶ 35.    Booth indicated that “[t]he new management team well known and

respected by Omega worked throughout 2016 to transform the culture of the

company, which included changing out many facility-level management teams.”

Id.     Booth acknowledged that during this “transition period” Orianna’s

operational performance dipped below 1x EBITDAR 5 coverage for 2016.                 Id.

However, in an effort to help Orianna during the transition period, Omega had

“embarked on an effort to sell off [Orianna’s] northwest region, which consisted

of 7 facilities,” and that “3 facilities [had] already been sold.” Id. at 25–26 ¶ 35.

Defendant Pickett added that Orianna was rebranding, moving its corporate

headquarters, and making significant business changes in an attempt to recover. 6

5
 EBITDAR stands for earnings before interest, taxes, depreciation, amortization, and
restructuring or rent cost; it measures profitability. As the district court noted, an
EBITDAR below 1x “represents significant cash flow issues.” SPA-3 n.3.
6Omega’s Form 10-Q for the first quarter of 2017, filed with the SEC on May 5, 2017,
described the following loss regarding Orianna’s recovery plan:

        In March 2017, we executed sale agreements with two unrelated third
        parties to sell the 7 Northwest facilities with a carrying value of
        approximately $36.4 million for $34.0 million. As a result, we recorded an
        allowance for loss of approximately $2.4 million. For the three months
        ended March 31, 2017, we recognized approximately $0.8 million of direct
        financing lease income on a cash basis related to the Northwest facilities

                                            6
       Defendants Stephenson and Pickett also stated that Orianna was 45 days

past due on its rent payments. 7 An analyst asked why Omega’s 2017 adjusted FFO

guidance, which had been estimated at $3.40 to $3.44 per diluted share, did not

reflect that Orianna was no longer paying rent. Id. at 31 ¶ 44. Defendant Pickett

responded that “at 45 days past due, to start fiddling around with guidance, just

doesn’t make any sense,” and reassured the analyst that Omega “feel[s] pretty

comfortable that [Orianna is] going to come back with coverages at [its] previous

       lease. The sale of these facilities is expected to close in the second quarter
       of 2017.

J.A. 327. The 10-Q also stated that there had been “no material changes to [Omega’s] risk
factors as previously disclosed . . . in Part 1 of our Annual Report on Form 10-K for the
fiscal year ended December 31, 2016,” and incorporated by reference the risk disclosures
in that document. Id. at 36 ¶ 51. Notably, the “risk factors” disclosure in Omega’s 2016
10-K stated that the company was “exposed to the risk that a distressed or insolvent
operator may not be able to meet its lease, loan, mortgage, or other obligations,” but did
not mention any risks specific to Orianna. Id. at 756.

7
 Stephenson and Pickett’s statements do not clearly indicate whether Orianna was 45
days past due as of the end of the first quarter, i.e., on March 31, 2017, or whether Orianna
was 45 days past due as of the date of the conference call, i.e., May 4, 2017. Because both
parties and the district court assume that the 45-day disclosure described Orianna’s
arrears for the first quarter, we assume that Stephenson and Pickett’s disclosure
communicated that Orianna was 45 days past due on its rental payments as of March 31,
2017.
                                             7
level.” Id. Omega did not mention the Loan in the conference call or in any of its

first quarter filings.

              B.     Second Quarter: April 1, 2017 through June 30, 2017

       Orianna continued to experience problems during the second quarter of

2017. Nevertheless, on July 26, 2017, Omega issued a press release revising

Omega’s guidance on FFO upwards to between $3.42 and $3.44 “per diluted

share.” J.A. 40 ¶ 59.

       Prior to Omega’s July 27, 2017 second quarter conference call, analysts

following Omega raised concerns regarding Orianna’s ability to pay rent. One

analyst issued a report focusing on Orianna’s rent delinquency, indicating that he

was “look[ing] to hear more about what [rent] payments (if any) were recouped

from [Orianna] after [the first quarter] shortfall.” J.A. 37–38 ¶ 54. Another analyst

report emphasized that “[t]enant health remains an issue for [Omega’s] portfolio”

such that two tenants “are now more than 30-days late on their rental payments

. . . highlight[ing] potential material risks to the near-term income stream.” Id. at

38–39 ¶ 55. Plaintiffs allege that one of the two tenants referred to in this report is

Orianna. Id. at 39 ¶ 56.

                                          8
      During Omega’s conference call, Booth reported that while Omega was

“optimistic” that coverages had stabilized, Omega “continue[d] to see certain

regional operators struggle with various operational pressures,” including

Orianna. Id. at 41–42 ¶ 61.

      Booth then explained that while Omega was “consciously [sic] optimistic

that the combination of . . . [Orianna’s] efforts will result in steadily improving

margins and eventually return to its former profitability,” the “past due rent has

reached nearly ninety days in arrears.” Id. He suggested that “any further

deterioration and/or failure of [Orianna] to achieve its budgeted plan may result

in cash basis accounting and a potential review of the value of these capital lease

assets.” 8 Id. at 42 ¶ 61. Booth emphasized, however, that efforts were being taken

to “manage through [certain] operational pressures,” including a “very recent and

significant downsizing of both corporate and regional staff.” Id. Omega did not

disclose the Loan. Following the conference call, Omega’s stock fell four percent.

8
 Under the “accrual basis” method of accounting, “revenue is recognized when earned.”
See Ironworkers Local 580—Joint Funds v. Linn Energy, LLC, 29 F. Supp. 3d 400, 408 n.3
(S.D.N.Y. 2014) (citing Joel G. Siegel, DICTIONARY OF ACCOUNTING TERMS 65 (3d ed. 2000)).
Under the “cash basis” method of accounting, “revenues are recognized when cash is
received (as opposed to earned).” Id. at 410 n.5.
                                           9
      Omega’s 10-Q for the second quarter made similar statements, including

that Orianna “has been facing liquidity pressures following a management

transition, but has been showing signs of operational improvement and is currently

making partial monthly rent payments.” Id. at 43 ¶ 64 (emphasis added). The

Complaint alleges that this statement and the statements made by Booth during

the July 27, 2017 conference call were “false and misleading” because those

statements implied that Orianna had been making rent payments from its own

operating income, when at least part of those rent payments was funded by the

undisclosed loan Omega had extended to Orianna several months earlier. Id. at

26 ¶ 36, 42–44 ¶¶ 62, 64, 65. Plaintiffs assert that Omega’s repeated failure to

disclose the existence of the Loan was part of a “surreptitious[]” scheme “to avoid

disclosing to the market both the gravity of Orianna’s financial woes and the likely

impact on Omega’s financial results.” Id. at 28 ¶ 39.

      The 10-Q also explained that “[t]he current management of [Orianna] is

pursuing    operational     improvements,”       including    “replacing    executive

management and senior level management, renegotiating vendor contracts and

establishing a centralized referral network.” Id. at 43–44 ¶ 64. Moreover, Omega

“expect[ed] to sell two other facilities and transition its existing Texas portfolio to

                                          10
another operator during the third quarter of 2017” and was “optimistic that the

combination of these efforts will result in improving margins and performance by

this operator.” Id. at 44 ¶ 64. The 10-Q specifically noted, however, that while

Omega “is currently recording rental revenue from this provider on an accrual

basis,” it will “continue[] to monitor [Orianna’s] operating plan and in the event

its performance deteriorates, [it] will reassess the carrying value of the portfolio

and consider recording future rental revenue on a cash basis.” Id. Omega did not

disclose the Loan during the second quarter.

      Following these statements, another analyst emphasized the general

concern over Orianna’s ability to pay rent. Id. at 45 ¶ 66 (“[I]nvestors were more

concerned with the health of two [of Omega’s] top ten tenants [including Orianna]

. . . who continue to not be current on their rents.”).

             C.     Third Quarter: July 1, 2017 through October 31, 2017

      By the end of the third quarter, Orianna had not achieved its recovery goals.

Omega placed Orianna on a cash basis, recognizing no revenue for Orianna for the

quarter.   On October 30, 2017, Omega issued a press release, disclosing

impairments of $194.7 million on direct financing leases and $9.5 million in

provisions for uncollectible accounts related to Orianna, contributing to an overall

                                          11
$46.8 million loss of FFO. J.A. 46–48, 613–17. Omega described the financial losses

as follows:

      During our second quarter earnings call, we stated we were closely
      monitoring one of our operators and may have to place them on a
      cash basis for revenue recognition if their performance did not
      improve. Since Orianna did not achieve their revised operating plan and
      pay their full contractual rent, we placed them on a cash basis and therefore
      our third quarter results, including AFFO [“Adjusted Funds From
      Operation”] and FAD [“Funds Available For Distribution”], do not include
      any revenue related to Orianna . . . . Since 93% of our Orianna portfolio
      was classified as a direct financing lease, placing them on a cash basis
      and initiating the process to transition some or all of their portfolio to
      new operators also required us to record several large provisions related
      to the direct financing leases during the quarter . . . . We are lowering our
      2017 guidance to reflect the temporary loss of third and fourth quarter 2017
      revenue primarily related to placing Orianna . . . on a cash basis.

Id. at 48 (emphasis added).

      The next day, Omega held a conference call to discuss its third quarter

results.   On the call, Defendant Pickett, Omega’s CEO acknowledged “[t]he

reduction in adjusted FFO . . . is primarily related to converting the Orianna

portfolio to cash basis accounting.”         Id. at 49 ¶ 69.     Similarly, Defendant

Stephenson indicated, “[w]e have lowered our 2017 adjusted FFO guidance to

$3.27 to $3.28 per share. The reduction . . . reflects the temporary loss of Orianna

revenue for both the third and fourth quarters.” Id. at 50. Defendant Booth added

                                           12
that while Omega “ha[s] endeavored to assist Orianna in streamlining operations

by transitioning both their Northwest and Texas regions, the overall portfolio

continues to struggle in past due rent headwind” and “has fallen significantly

behind on rent.” Id. Following the conference call, Omega’s stock fell 6.8 percent.

      On November 7, 2017, Omega filed its 10-Q for the third quarter, which

noted that it had restructured two of Orianna’s direct financing leases, resulting in

impairments totaling $20.8 million, that “Orianna ha[d] not satisfied the

contractual payments due under the terms of the remaining two direct financing

leases or the separate operating lease with [Omega] and the collectability of future

amounts due is uncertain,” and that Omega was “in preliminary discussions with

Orianna regarding future actions.” Id. at 52 ¶ 71.

      In March 2018, Orianna filed for bankruptcy. Id. at 22 ¶ 29.

      II.    Litigation History

      Following numerous procedural matters not relevant here, 9 Plaintiffs filed

their Consolidated Amended Class Action Complaint (the “Complaint”) on behalf

9
 Plaintiff Dror Gronich filed his action on November 16, 2017. Steve Klein filed a similar
complaint on November 17, 2017. On March 27, 2018, the district court (Buchwald, J.)
appointed Royce Setzer as lead plaintiff, consolidated this action with Klein v. Omega
Healthcare Plaintiffs, Inc., No. 17-cv-09024-NRB, and approved Setzer’s selection of lead
counsel.
                                           13
of themselves and all persons who purchased or otherwise acquired Omega’s

securities during the Class Period. Several months thereafter, Defendants filed a

motion to dismiss the Complaint.

         The district court granted Defendants’ motion, determining that although

“plaintiffs ha[d] sufficiently alleged materiality with respect to the omission of the

[Loan,]” the “failure to plead a strong inference of scienter [was] fatal” to their

claim. SPA-18. 10 The district court found that Plaintiffs failed to allege that Omega

acted recklessly because the Complaint failed to allege any GAAP violation and

because Omega had “disclosed Orianna’s financial predicament repeatedly to

investors” in the May and July 2017 disclosures. SPA-23–24. Because Plaintiffs

failed to plead a primary Section 10(b) violation, the court also dismissed

Plaintiffs’ Section 20(a) claims.

         The district court entered judgment and this appeal followed.

                                       DISCUSSION

         Under Section 10(b) of the Exchange Act, it is unlawful to “use or employ,

in connection with the purchase or sale of any security . . . any manipulative or

10
     Citations to the SPA refer to the Special Appendix.
                                              14
deceptive device or contrivance in contravention of [the] rules and regulations”

that the SEC prescribes. 15 U.S.C. § 78j(b). Rule 10b–5 implements Section 10(b),

and makes it unlawful

      (a) To employ any device, scheme, or artifice to defraud,
      (b) To make any untrue statement of a material fact or to omit to state
      a material fact necessary in order to make the statements made, in the
      light of the circumstances under which they were made, not
      misleading, or
      (c) To engage in any act, practice, or course of business which operates
      or would operate as a fraud or deceit upon any person, in connection
      with the purchase or sale of any security.

17 C.F.R. § 240.10b–5.

      To state a claim under Section 10(b) and Rule 10b–5, “a plaintiff must allege

that the defendant (1) made misstatements or omissions of material fact, (2) with

scienter, (3) in connection with the purchase or sale of securities, (4) upon which

the plaintiff relied, and (5) that the plaintiff’s reliance was the proximate cause of

its injury.” ATSI Commc’ns, Inc. v. Shaar Fund, Ltd., 493 F.3d 87, 105 (2d Cir. 2007)

(citation omitted). A complaint alleging securities fraud must also satisfy the

heightened pleading requirements of Federal Rule of Civil Procedure 9(b), which

requires that the “circumstances constituting fraud” be “state[d] with

                                         15
particularity.” Fed. R. Civ. P. 9(b). “Malice, intent, [and] knowledge,” however,

“may be alleged generally.” Id.

      The principal issue before us is whether the district court erred in finding

that the Complaint failed to adequately plead scienter. To adequately plead

scienter under the Private Securities Litigation Reform Act of 1995 (the “PSLRA”),

Pub. L. No. 104–67, 109 Stat. 737 (1995), a plaintiff must allege facts giving rise to

a “strong inference that the defendant acted with the required state of mind.” 15

U.S.C. § 78u-4(b)(2)(A). The requisite state of mind in a Rule 10b–5 action is “an

intent to deceive, manipulate or defraud.” Ganino v. Citizens Utilities Co., 228 F.3d

154, 168 (2d Cir. 2000) (citation omitted). In this Circuit, plaintiffs can satisfy this

requirement by “alleging facts (1) showing that the defendants had both motive

and opportunity to commit the fraud or (2) constituting strong circumstantial

evidence of conscious misbehavior or recklessness.” ATSI Commc'ns, 493 F.3d at

99 (citation omitted). A complaint will survive “only if a reasonable person would

deem the inference of scienter cogent and at least as compelling as any opposing

inference one could draw from the facts alleged.” Tellabs, Inc. v. Makor Issues &

Rights, Ltd., 551 U.S. 308, 324 (2007).

                                          16
       I.     Plaintiffs Adequately Allege Defendants’ Duty to Disclose the
              Loan

       Plaintiffs’ theory of scienter is based primarily in recklessness. 11             In

securities fraud cases alleging a material omission, our recklessness standard

requires that Plaintiffs allege a clear duty to disclose, see Kalnit v. Eichler, 264 F.3d

131, 144 (2d Cir. 2001), and further allege facts supporting a strong inference of

“conscious recklessness—i.e., a state of mind approximating actual intent, and not

merely a heightened form of negligence,” Stratte-McClure v. Morgan Stanley, 776

F.3d 94, 106 (2d Cir. 2015); see also In re Carter-Wallace, Inc. Sec. Litig., 220 F.3d 36,

39 (2d Cir. 2000) (to plead recklessness, a plaintiff must allege “conduct which is

highly unreasonable and which represents an extreme departure from the

11
  The district court also found that Plaintiffs failed to establish scienter via motive and
opportunity. See SPA-21. On appeal, Plaintiffs concede that “the Complaint’s allegations
of motive on their own may not suffice to plead a strong inference of scienter.”
Appellants’ Br. 39. Plaintiffs argue, however, that the district court erred in disregarding
Omega’s motive to protect the performance of its portfolio in analyzing scienter
holistically. See Appellants’ Br. 39–41. Accordingly, while we agree that we must assess
Plaintiffs’ scienter claim holistically, we will not consider whether the Complaint
sufficiently alleged scienter under this Circuit’s “motive and opportunity” theory of
liability.
                                            17
standards of ordinary care to the extent that the danger was either known to the

defendant or so obvious that the defendant must have been aware of it”). 12

       Plaintiffs argue that Defendants were duty-bound to disclose the Loan

because the failure to do so rendered statements about Orianna’s performance

actionably misleading. See Appellants’ Br. 29–31, 41–51; Appellants’ Reply Br. 13–

16. We agree.

12Although the materiality of Defendants’ omission is not at issue here, the distinction
between materiality analysis and the recklessness prong of scienter warrants some
attention. A defendant’s duty to disclose often depends on the importance of the omitted
information under the circumstances. Thus, at times, recklessness analysis resembles
materiality analysis, which asks whether there is “a substantial likelihood that the
disclosure of the omitted fact would have been viewed by the reasonable investor as
having significantly altered the total mix of information made available.” Basic Inc. v.
Levinson, 485 U.S. 224, 231–32 (1988) (citation omitted). However, recklessness in the
context of scienter ultimately turns on the extent of the defendant’s departure from “the
standards of ordinary care.” See, e.g., In re Carter-Wallace, 220 F.3d at 39, 41. Moreover,
materiality is a mixed question of law and fact, rarely resolved at the motion to dismiss
stage. See ECA, Local 134 IBEW Joint Pension Trusts of Chi. v. JP Morgan Chase Co., 553 F.3d
187, 197 (2d Cir. 2009). In contrast, adequately pleading scienter requires a “strong
inference” which is at least as “cogent and compelling” as any opposing inference.
Tellabs, 551 U.S. at 314, 324. As such, where, as here, the duty to disclose is based on a
requirement to disclose “material fact[s] necessary in order to make the statements made,
in the light of the circumstances under which they were made, not misleading,” 17 C.F.R.
§ 240.10b–5(b), and the recklessness inquiry requires assessing the seriousness of the
defendant’s departure from its duty to disclose, see infra Part II, the seriousness required
to adequately allege recklessness must typically go beyond the materiality showing
required to allege a duty to disclose. In a phrase, the allegations must be sufficiently
serious as to create “a strong inference” of scienter. Tellabs, 551 U.S. at 314. As we explain
below, Plaintiffs have met this burden here.
                                             18
      Omega’s duty to disclose the Loan arose directly from Rule 10b–5’s

requirement to disclose “material fact[s] necessary in order to make the statements

made, in the light of the circumstances under which they were made, not

misleading.” 17 C.F.R. § 240.10b–5(b); see also Stratte-McClure, 776 F.3d at 101 (“[A]

duty [to disclose omitted facts] may arise when there is . . . a corporate statement

that would otherwise be inaccurate, incomplete, or misleading.” (internal

quotation marks and citation omitted)). A review of Defendants’ statements

makes clear that, without disclosing the existence of the Loan, Defendants’

statements regarding Orianna’s rent payments gave a false impression of the

financial health of one of Omega’s largest assets.

      On May 4, 2017, Defendants told analysts and investors that, as of March 31,

2017, Orianna was “45 days past due” on its rental payments. J.A. 301. Defendants

later indicated that, as of June 30, 2017, Orianna was “approximately 90 days past

due on rent payments,” but that it was “currently making partial monthly rent

payments.” Id. at 590. By failing to disclose that the Loan accounted for all (or

most) of Orianna’s “partial monthly rent payments,” 13 Defendants effectively

13
  In a filing before the Bankruptcy Court, Orianna disclosed that “[m]ost of the proceeds
of the [Loan] were used by [Orianna] to pay rent and real property taxes.” J.A. 26.

                                           19
communicated that, notwithstanding any disclosures regarding Orianna’s

performance issues, Orianna could pay more than half of its rent from its

earnings. 14 The omission concealed the extent of Orianna’s solvency problems:

Orianna could not pay rent without borrowing from its landlord. Under the facts

as alleged, because in July 2017 Omega had stated that Orianna was making

“partial monthly payments,” Omega was duty-bound to disclose that its loan was

the source of Orianna’s rent payments. 15

Moreover, the Complaint alleges that the primary purpose of the Loan was to enable
“Orianna to cover real estate taxes and to pay rent back to Omega.” Id. at 44. The strong
inference is that Orianna could not have made its “partial monthly rent payments” but
for the Loan.
14
  Had Orianna not made any rent payments after March 31, 2017, it would have been 137
days in arrears as of June 30, 2017. Defendants’ statements that Orianna was only 90 days
past due as of June 30, 2017 conveyed that Orianna had made 47 days’ worth of rent
payments during the second quarter of 2017—representing payments for over half of the
92-day quarter.
15
  Because we find that Omega’s duty to disclose the Loan arose under Rule 10b–5, we
need not address Plaintiffs’ argument that Item 303 imposed an independent duty on
Omega to disclose the Loan. See Appellants’ Br. 35–37. Moreover, “[e]ven when there is
no existing independent duty to disclose information, once a company speaks on an issue
or topic, there is a duty to tell the whole truth.” Meyer v. Jinkosolar Holdings Co., Ltd., 761
F.3d 245, 250 (2d Cir. 2014) (citation omitted). Thus, by putting Orianna’s rental
payments “in play,” Defendants were required to speak accurately and completely. See
id. at 250–51 & n.3 (citation omitted); see also Caiola v. Citibank, N.A., New York, 295 F.3d
312, 331 (2d Cir. 2002) (“[T]he lack of an independent duty is not . . . a defense to Rule
10b–5 liability because upon choosing to speak, one must speak truthfully about material
issues. Once [Defendant] chose to discuss its hedging strategy, it had a duty to be both

                                              20
      II.    Plaintiffs Adequately Allege Facts Showing Omega’s Recklessness

      Although the existence of a clear duty to disclose the omitted information is

necessary to state a claim under a recklessness theory of scienter, a plaintiff must

also allege facts showing the defendant’s “conscious recklessness—i.e., a state of

mind approximating actual intent, and not merely a heightened form of

negligence.” Novak v. Kasaks, 216 F.3d 300, 312 (2d Cir. 2000) (internal quotation

marks and citation omitted). In other words, the facts alleged in the Complaint

must support the conclusion that Omega’s non-disclosure of the Loan was at least

“highly unreasonable and . . . represent[ed] an extreme departure from the

standards of ordinary care to the extent that the danger was either known to the

defendant or so obvious that the defendant must have been aware of it.” S. Cherry

St., LLC v. Hennessee Grp. LLC, 573 F.3d 98, 109 (2d Cir. 2009) (internal quotation

marks, emphasis, and citation omitted); see also In re Carter-Wallace, 220 F.3d at 39.

The question is: Was Omega’s decision not to disclose the Loan—in the context of

accurate and complete.” (citations omitted)). We do not understand these references to
the “whole truth” and to speaking “completely” to describe a duty to disclose all the facts
that pertain to a subject (many of which would be immaterial), but instead to describe a
duty not to omit material facts whose omission, in the light of what was stated, would be
misleading. See 17 C.F.R. § 240.10b–5(b) (“It shall be unlawful . . . to omit to state a
material fact necessary in order to make the statements made, in the light of the
circumstances under which they were made, not misleading . . . .”).
                                            21
its disclosures regarding Orianna’s financial health—a sufficiently extreme

departure from the standards of ordinary care to satisfy the PSLRA’s requirement

for showing recklessness?

      It was. We have previously explained that “securities fraud claims typically

have sufficed to state a claim based on recklessness when they have specifically

alleged defendants’ knowledge of facts or access to information contradicting their

public statements.” Novak, 216 F.3d at 308. Thus, in determining whether the

Complaint adequately alleges facts giving rise to a strong inference that

Defendants acted recklessly, we focus on Defendants’ degree of knowledge and

the seriousness of the impact that results from their conduct. See id. (discussing

various examples of recklessness sufficient for Section 10(b) liability).

      Here, the allegations in the Complaint raise a strong inference that

Defendants acted, at the very least, recklessly in choosing to disclose incomplete

and misleading information regarding Orianna. As the district court noted, there

is no question that the inability of one of Omega’s “top” tenants to pay rent absent

the Loan was material.      See SPA-18.    Orianna represented seven percent of

Omega’s investment portfolio; it was a significant source of income through rental

payments. See J.A. 21 ¶ 28; see also id. at 523 (explaining that Orianna’s rent

                                          22
obligations to Omega amounted to $44 million per year, or roughly $11 million per

quarter).   Orianna’s performance plainly impacted Omega’s overall financial

health; Omega had to know that revealing the full extent of Orianna’s performance

problems would have been troubling news to its investors.

       Moreover, assuming most of the Loan proceeds were used to pay Orianna’s

rent during the second quarter—as the Complaint alleges, see id. at 26 ¶ 36, 31–33

¶¶ 45, 47—Omega knew that its money would be going directly back into its FFO

and/or AFFO. Nevertheless, Defendants chose to represent these numbers as

“partial monthly payments” indicating that Orianna was on the road to recovery. 16

The facts as alleged create a compelling inference that Defendants made a

conscious decision to not disclose the Loan in order to understate the extent of

Orianna’s financial difficulties.      This is especially convincing where multiple

16
  In dismissing the Complaint, the district court seemed to focus on the fact that Plaintiffs
“fail[ed] to allege a GAAP violation or other accounting irregularity.” SPA-23. While
loaning money to a tenant to pay its rent and then expressing optimism about that
tenant’s performance because it is making “partial monthly payments” may not violate
GAAP, it is still seriously misleading under the facts as alleged here.
                                             23
analysts homed in on Orianna’s rental payments being key to Omega’s prospects.

See id. at 37–39, ¶¶ 54–55. 17

       That Defendants made several disclosures regarding Orianna’s financial

difficulties does not alter our conclusion. Indeed, those disclosures support a

finding of recklessness here as they strongly suggest that Defendants sought to use

Orianna’s “partial rental payments” to express optimism and underrepresent the

extent of those very problems.

       The facts alleged in the Complaint therefore support a strong inference that

Defendants’ failure to disclose the Loan constituted “conscious misbehavior,”

Kalnit, 264 F.3d at 144, or, at the very least, “highly unreasonable [conduct] . . .

[that] represents an extreme departure from the standards of ordinary care.”

Hennessee, 573 F.3d at 109. The inference is “at least as compelling as any opposing

inference one could draw from the facts alleged.” Tellabs, 551 U.S. at 314. Reversal

of the district court’s decision is therefore in order.

17
  While not dispositive, we also note that Omega had previously disclosed the possibility
of a working capital loan to another troubled operator. See, e.g., J.A. 522. It is therefore
somewhat suspect that Omega did not make a similar disclosure about the Loan, which
had already been made, in its discussions about Orianna.
                                            24
       III.   Plaintiffs’ Section 20(a) Claims

       Finally, Plaintiffs also allege control person liability under Section 20(a) of

the Exchange Act. See 15 U.S.C. § 78t(a). The district court held that Plaintiffs’

failure to state a claim under Section 10(b) precluded relief under Section 20(a).

See SPA-29 (citing, inter alia, SEC v. First Jersey Sec., Inc., 101 F.3d 1450, 1472 (2d Cir.

1996)). Because we disagree with the district court’s determination as to scienter,

we also reverse the district court’s dismissal of the Section 20(a) claims and remand

for further proceedings consistent with this opinion.

                                    CONCLUSION

       For the reasons stated above, we REVERSE the judgment of the district

court and REMAND for further proceedings consistent with this opinion.

                                            25